WHO's Reckless Vaccine Approval Endangers Children’s Health
Submitted by MAGA
Posted 70 days ago
**Scandalous Decision by WHO Raises Concerns Over Vaccine Safety for Children**
In a shocking move that has alarmed health experts and parents alike, the World Health Organization (WHO) has approved the first mpox vaccine for use not only in adults but also for infants, children, and pregnant women—all without adequate clinical trials ensuring safety and efficacy.
The MVA-BN vaccine, which is marketed as Jynneos in the United States, is being touted by the WHO as a necessary step to combat mpox outbreaks in Africa.
However, critics are raising serious questions about the decision, noting the troubling safety profile associated with the vaccine in adults and the complete lack of data on how it affects younger populations.
Brian Hooker, Chief Scientific Officer at Children’s Health Defense, called the approval “a train wreck in the making,” emphasizing that the vaccine has garnered serious adverse events, including cardiovascular issues, in adult trials without any assurance that it is safe for children.
This course of action from the WHO comes on the heels of dire public health crises across Africa, where diseases such as malaria and tuberculosis continue to claim countless lives annually. Dr. David Bell, a former WHO officer, has expressed frustration that the organization continues to focus resources on newer, rarer diseases instead of addressing these life-threatening conditions.
While the WHO claims that this vaccine's benefits may outweigh risks in outbreak scenarios, the lack of pediatric clinical trials poses profound ethical concerns. The organization has admitted that similar vaccines have not been thoroughly studied in children, stating that "more data" is needed regarding the safety of the MVA-BN vaccine in younger demographics before it can be recommended confidently.
Moreover, the decision to allow off-label use of the vaccine in babies and young children is particularly controversial given that the U.S. Centers for Disease Control and Prevention (CDC) has previously indicated hesitance regarding administering Jynneos to infants suggesting that it is not recommended for babies under six months.
This situation underscores a broader pattern of alarming decisions made by international health organizations that prioritize speed and emergency authorization over the rigorous scientific processes typically required when developing medical treatments.
In a political environment increasingly skeptical of global health authorities, calls for transparency and accountability have never been more urgent. As governments and health agencies deliberate on how to respond to health crises, it is crucial they prioritize safety, ensuring that any interventions, especially those involving vulnerable populations like children, are thoroughly vetted for potential risks.
The implications of this decision by the WHO necessitate an informed discourse as parents and guardians deserve clarity about what vaccines are deemed safe for their little ones. It is a troubling moment that raises significant questions about the direction of global public health initiatives, particularly as they relate to children's health.
Sources:
basedunderground.com
twitchy.com
thecollegefix.com
In a shocking move that has alarmed health experts and parents alike, the World Health Organization (WHO) has approved the first mpox vaccine for use not only in adults but also for infants, children, and pregnant women—all without adequate clinical trials ensuring safety and efficacy.
The MVA-BN vaccine, which is marketed as Jynneos in the United States, is being touted by the WHO as a necessary step to combat mpox outbreaks in Africa.
However, critics are raising serious questions about the decision, noting the troubling safety profile associated with the vaccine in adults and the complete lack of data on how it affects younger populations.
Brian Hooker, Chief Scientific Officer at Children’s Health Defense, called the approval “a train wreck in the making,” emphasizing that the vaccine has garnered serious adverse events, including cardiovascular issues, in adult trials without any assurance that it is safe for children.
This course of action from the WHO comes on the heels of dire public health crises across Africa, where diseases such as malaria and tuberculosis continue to claim countless lives annually. Dr. David Bell, a former WHO officer, has expressed frustration that the organization continues to focus resources on newer, rarer diseases instead of addressing these life-threatening conditions.
While the WHO claims that this vaccine's benefits may outweigh risks in outbreak scenarios, the lack of pediatric clinical trials poses profound ethical concerns. The organization has admitted that similar vaccines have not been thoroughly studied in children, stating that "more data" is needed regarding the safety of the MVA-BN vaccine in younger demographics before it can be recommended confidently.
Moreover, the decision to allow off-label use of the vaccine in babies and young children is particularly controversial given that the U.S. Centers for Disease Control and Prevention (CDC) has previously indicated hesitance regarding administering Jynneos to infants suggesting that it is not recommended for babies under six months.
This situation underscores a broader pattern of alarming decisions made by international health organizations that prioritize speed and emergency authorization over the rigorous scientific processes typically required when developing medical treatments.
In a political environment increasingly skeptical of global health authorities, calls for transparency and accountability have never been more urgent. As governments and health agencies deliberate on how to respond to health crises, it is crucial they prioritize safety, ensuring that any interventions, especially those involving vulnerable populations like children, are thoroughly vetted for potential risks.
The implications of this decision by the WHO necessitate an informed discourse as parents and guardians deserve clarity about what vaccines are deemed safe for their little ones. It is a troubling moment that raises significant questions about the direction of global public health initiatives, particularly as they relate to children's health.
Sources:
basedunderground.com
twitchy.com
thecollegefix.com
Latest News